597 related articles for article (PubMed ID: 15806475)
1. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.
Dong J; Li YJ; Yang ZK; Xu R
Perit Dial Int; 2014; 34(7):706-13. PubMed ID: 24584618
[TBL] [Abstract][Full Text] [Related]
5. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
6. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.
Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
Diabetes; 2000 Mar; 49(3):485-91. PubMed ID: 10868972
[TBL] [Abstract][Full Text] [Related]
8. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
Wang AY; Woo J; Lam CW; Wang M; Sea MM; Lui SF; Li PK; Sanderson J
J Am Soc Nephrol; 2003 Jul; 14(7):1871-9. PubMed ID: 12819248
[TBL] [Abstract][Full Text] [Related]
9. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.
Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):593-8. PubMed ID: 11950696
[TBL] [Abstract][Full Text] [Related]
11. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients.
Ateş K; Ateş A; Ekmekçi Y; Nergizoglu G
Perit Dial Int; 2005; 25(3):256-68. PubMed ID: 15981774
[TBL] [Abstract][Full Text] [Related]
12. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients.
Wang AY; Sea MM; Tang N; Sanderson JE; Lui SF; Li PK; Woo J
J Am Soc Nephrol; 2004 Dec; 15(12):3134-43. PubMed ID: 15579517
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Goggins WB; Yu CM; Lui SF; Sanderson JE
Clin Chem; 2007 May; 53(5):882-9. PubMed ID: 17395709
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients.
Bonomini M; Reale M; Santarelli P; Stuard S; Settefrati N; Albertazzi A
Nephron; 1998 Aug; 79(4):399-407. PubMed ID: 9689154
[TBL] [Abstract][Full Text] [Related]
15. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
[TBL] [Abstract][Full Text] [Related]
17. The impact of residual renal function on quality of life in patients with peritoneal dialysis
.
Zhou W; Hu W; Han G; Wang H; Zhang J; Mei C
Clin Nephrol; 2018 Aug; 90(2):106-111. PubMed ID: 29932407
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell adhesion molecules and death in patients with coronary artery disease.
Blankenberg S; Rupprecht HJ; Bickel C; Peetz D; Hafner G; Tiret L; Meyer J
Circulation; 2001 Sep; 104(12):1336-42. PubMed ID: 11560847
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease.
Attalah MF; Adel LA; Fahmy DE
Egypt J Immunol; 2011; 18(2):59-66. PubMed ID: 23082471
[TBL] [Abstract][Full Text] [Related]
20. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
